Journal article
Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study
Abstract
BACKGROUND: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development.
METHODS: We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals with self-reported cardiovascular disease from 21 countries enrolled in the Prospective Urban Rural Epidemiology (PURE) study. Defining one or more …
Authors
Murphy A; Palafox B; O'Donnell O; Stuckler D; Perel P; AlHabib KF; Avezum A; Bai X; Chifamba J; Chow CK
Journal
The Lancet Global Health, Vol. 6, No. 3, pp. e292–e301
Publisher
Elsevier
Publication Date
3 2018
DOI
10.1016/s2214-109x(18)30031-7
ISSN
2572-116X